LoginRegister

    Editor's Pick

    View All

    Latest News

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Medical Dialogues Bureau
    Delhi: Indian Pharma industry is producing enough stocks of essential medicines particularly HCQ to meet both domestic demands and to meet export...
    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Medical Dialogues Bureau
    Mumbai: The Joint Managing Director of Ipca Laboratories Ajit Kumar Jain on Saturday said that hydroxychloroquine is not approved as an anti-malarial...
    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Medical Dialogues Bureau
    "The funding will allow us to invest further into improving patient outcomes and generate further real-world evidence while expanding our therapeutic...
    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Medical Dialogues Bureau
    Mumbai: API producer, Lasa Supergenerics Ltd has forayed into the hormone and steroid API segment for Human application with its approval from the...
    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Medical Dialogues Bureau
    India: Through a recent release with the exchanges, SMS Pharma has provided update against USFDA statement on RanitidineSMS Pharma is one of the...
    View All

    Pharma News

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    Implants / Devices

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Philips to ramp up production of ventilators in coronavirus fight

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

    Meril Life Sciences gets 5 years exemption from NPPA for its MeRes100 stent

    View All

    Hospital & Diagnostic

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical...

    Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

    Capacit'e Infraprojects bags Rs 407 crore order in Mumbai

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    View All

    Insurance

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

    True North gets IRDAI nod to buy 51 pc stake in Max Bupa at enterprise value of Rs 1 crore

    Insurance coverage for CAR-T cell therapies from Novartis, Gilead get Swiss Govt nod

    View All

    Policy

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19

    Coronavirus Update: Sanitizers, surgical masks, n95 masks, gloves brought under Essential...

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    BA/BE study applications have to be processed in 15 days: CDSCO

    View All

    Investment

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    Yamma buys $200-mln minority stake in Turkish drug maker Sanovel

    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    View All

    Key Movement

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Lupin appoints J Alan Butcher as Chief Corporate Development Officer

    MSD India appoints Rehan A Khan as Managing Director

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

    View All

    AYUSH

    Patanjali group eyes to be Rs 40,000-crore company in 2020-21

    Patanjali group eyes to be Rs 40,000-crore company in 2020-21

    Hamdard Labs launches Wellness Centres in Ghaziabad, Meerut

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    AYUSH ministry launches e-AUSHADHI portal for online licensing of drugs

    View All
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X